早产儿视网膜病变的发病率与早期病程:G-ROP研究二次分析
该研究基于G-ROP回顾性队列中7483例接受系列眼底筛查的早产儿,分析早产儿视网膜病变(ROP)的发病率、发病时间和早期病程。结果显示43.1%发生ROP,6.1%为1型、6.3%为2型,6.9%接受治疗,2%有I区病变;98.1%的1型或2型ROP见于出生体重<1251 g的婴儿。
要点
- 43.1%的筛查早产儿发生ROP,多数无需治疗自行消退。
- 约12.5%发生严重ROP(1型或2型),几乎均见于出生体重<1251 g。
- 仅49.4%的眼在矫正胎龄37周时血管化进入III区。
核心结论
- 超过40%的接受筛查早产儿发生某期ROP,多数自行消退,约12.5%发生严重ROP且几乎仅见于出生体重<1251 g的婴儿。
研究设计与样本
- G-ROP回顾性队列研究的二次分析,纳入2006年1月至2011年12月美国与加拿大29家医院7483例接受系列ROP检查的婴儿。
主要发现
- 7483例婴儿平均(SD)出生体重1099(259)g,平均(SD)胎龄28(3)周。
- 3224例(43.1%)发生ROP,459例(6.1%)为1型、472例(6.3%)为2型,514例(6.9%)接受治疗,147例(2%)有I区病变。
- 98.1%的1型或2型ROP发生在出生体重<1251 g的婴儿中。
- 仅约半数眼(49.4%)在矫正胎龄37周时血管化进入III区。
关键数值与推荐
- ROP分类依据Early Treatment for ROP Study标准,分为无ROP、轻度ROP、2型ROP和1型ROP。
- 主要结局为任一眼最严重ROP,以及I区病变和ROP分期、附加病变、治疗的矫正胎龄发病时间。
临床怎么用
- 筛查中应关注出生体重<1251 g的早产儿,因其严重ROP风险最高。
- 多数ROP无需治疗即可消退,但需按规范随访以识别约12.5%发生严重ROP的患儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The current guidelines for retinopathy of prematurity (ROP) detection programs in the United States include a range of birth weights (BWs) and gestational ages and likely require examinations of many premature infants who are at low risk for developing serious retinopathy. OBJECTIVE: To determine the incidence, onset, and early course of ROP in what to our knowledge is the largest cohort to date that is representative of infants who are undergoing ROP screening. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of data from the Postnatal Growth and Retinopathy of Prematurity (G-ROP) retrospective cohort study was conducted in 29 hospitals in the United States and Canada between January 2006 and December 2011 and included 7483 infants who underwent serial ROP examinations. MAIN OUTCOMES AND MEASURES: Most severe ROP in either eye, classified as no ROP, mild ROP, type 2 ROP, or type 1 ROP (per Early Treatment for ROP Study criteria). Onset at postmenstrual age for zone I disease and stage of ROP, plus disease, and treatment. RESULTS: This study included 7483 infants with a mean (SD) BW of 1099 (259) g and a mean (SD) gestational age of 28 (3) weeks who underwent ROP examinations. Of these, 3224 infants (43.1%) developed ROP, 459 (6.1%) developed type 1 and 472 (6.3%) type 2 ROP, 514 (6.9%) underwent treatment in 1 or both eyes, and 147 (2%) had zone I disease. Additionally, 98.1% of type 1 or 2 ROP cases occurred in infants with a BW of less than 1251 g. Only about half of the eyes (49.4%) were vascularized into zone III by 37 weeks postmenstrual age. CONCLUSIONS AND RELEVANCE: These findings add to our knowledge of ROP screening as they include all eligible infants, not just high-risk infants as in previous studies. More than 40% of at-risk premature infants develop some stage of ROP, and most retinopathy regresses without treatment. However, approximately 12.5% develop severe ROP, which occurs almost exclusively among infants with a BW of less than 1251 g.
引用
- Quinn GE, Ying GS, Bell EF, et al. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018. PMID: 30326046. doi:10.1001/jamaophthalmol.2018.4290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。